Skip to main content

Table 2 Enabling factors for the dissemination, diffusion, scale up, or sustainability of DMPA by AIDED model components

From: Scaling up depot medroxyprogesterone acetate (DMPA): a systematic literature review illustrating the AIDED model

Enabling factor

# sources citing factor

AIDED model component(s) to which factor was mapped

Development of delivery system supports (training of health workers/field motivators, creation of training manuals or checklists, supply chain improvements, recruitment of women, chart tracking)

10

Develop

Tailoring innovation to existing system capacity (community-based distribution systems already in place, women in community health worker roles, other existing program infrastructure (e.g., well-baby clinics, current supply chain flows))

9

Innovate, Devolve

Landscape or stakeholder assessment

6

Assess

Collaboration with stakeholders to identify or create supportive structures in the economic, political and technological spheres

6

Assess, Develop

Use of social networks

5

Devolve

Dialogue with community at early stages

5

Assess, Engage

Effective education through social marketing regarding risks and instructions (including community input)

4

Develop, Engage

Piloting to determine feasibility

3

Assess

Innovation design features (e.g., injectable at 3 month intervals)

3

Innovate

Ensuring ‘fit’ with cultural norms (e.g., allowing women to take injections in strict confidence without being observed)

3

Assess, Innovate

Use of data to improve program performance

3

Engage

Nationalistic messaging (e.g., population control)

2

Develop

Adherence to religious norms (e.g., support of leaders)

1

Innovate, Develop, Engage

Identifying potential sources of resistance, such as from the professional medical community

1

Assess

Creating structures to ensure use of assessment findings through implementation and scale up (e.g., the same individuals that conducted the assessment remained involved throughout the process of scaling)

1

Assess